Cryptococcus neoformans var. gattii can exploit Acanthamoeba castellanii for growth

Medical Mycology

Volumn 42, Issue 2, 2004, Pages 149-158

  Malliaris, Stephanie D ^a   Steenbergen, Judith N ^b   Casadevall, Arturo ^a,b  

^a Division of Infectious Diseases   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

C. neoformans var. gattii; Environmental; Phagocytosis; Virulence

Indexed keywords

POLYSACCHARIDE;

ACANTHAMOEBA CASTELLANII; AMOEBA; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; FUNGAL VIRULENCE; FUNGUS GROWTH; HOST PARASITE INTERACTION; MACROPHAGE; NEMATODE; NONHUMAN; PHAGOCYTOSIS; QUANTITATIVE ANALYSIS; SCANNING ELECTRON MICROSCOPY; SOIL MICROFLORA; STUDENT T TEST; TRANSMISSION ELECTRON MICROSCOPY;

ACANTHAMOEBA; ANIMALS; CRYPTOCOCCUS NEOFORMANS; MICROSCOPY, ELECTRON; SOIL MICROBIOLOGY; VIRULENCE;

ACANTHAMOEBA; ACANTHAMOEBA CASTELLANII; CRYPTOCOCCUS BACILLISPORUS; FILOBASIDIELLA NEOFORMANS; FUNGI; NEMATODA; VERTEBRATA;

EID: 1842863497     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/13693786310001616500     Document Type: Article

References (33)

1. Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol 1999; 37: 838-40.
2. Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 1991; 13: 1163-1169.
3. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984; 120: 123-130.
4. Bennett JE, Kwon-Chung KJ, Howard DH. Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol 1977; 105: 582-586.
5. Escandon P, Huerfano S, Castaneda E. 2002; [Experimental inoculation of Terminalia catappa seedlings with an environmental isolate of Cryptococcus neoformans var. gattii serotype C]. Biomedica (Bogota) 22: 524-528. [In Spanish.]
6. Sorrell TC. Cryptococcus neoformans variety gattii. Med Mycol 2001; 39: 155-168.
7. Ellis DH, Pfeiffer TJ. Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol 1990; 28: 1642-1624.
8. Chen S, Sorrell T, Nimmo G, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis 2000; 31: 499-508.
9. Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995; 21: 28-34 (Discussion paper, 35-36)
10. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS -100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8: 515-548.
11. Boekhout T, Theelen B, Diaz M, et al. Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiology 2001; 147: 891-907.
12. Kwon-Chung KJ, Bennett JE. Medical Mycology. Philadelphia: Lea & Febiger, 1992.
13. Steenbergen JN, Shuman HA, Casadevall A. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci USA 2001; 98: 15245-15250.
14. Rodriguez-Zaragoza S. Ecology of free-living amoebae. Crit Rev Microbiol 1994; 20: 225-241.
15. Barker J, Brown MR. Trojan horses of the microbial world: protozoa and the survival of bacterial pathogens in the environment. Microbiology 1994; 140: 1253-1259.
16. Feldmesser M, Kress Y, Novikoff P, Casadevall A. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun 2000; 68: 4225-4237.
17. Bulmer GS, Sans MD, Gunn CM. Cryptococcus neoformans. I. Nonencapsulated mutants. J Bacteriol 1967; 94: 1475-1479.
18. Bozue JA, Johnson W. Interaction of Legionella pneumophila with Acanthamoeba castellanii: uptake by coiling phagocytosis and inhibition of phagosome-lysosome fusion. Infect Immun 1996; 64: 668-673.
19. Moffat JF, Tompkins LS. A quantitative model of intracellular growth of Legionella pneumophila in Acanthamoeba castellanii. Infect Immun 1992; 60: 296-301.
20. Casadevall A, Cleare W, Feldmesser M, et al. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother 1998; 42: 1437-1446.
21. Levitz SM, Nong SH, Seetoo KF, et al. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect Immun 1999; 67: 885-890.
22. Wang Y, Aisen P, Casadevall A. Cryptococcus neoformans melanin and virulence: mechanism of action. Infect Immun 1995; 63: 3131-3136.
23. Nosanchuk JD, Valadon P, Feldmesser M, Casadevall A. Melanization of Cryptococcus neoformans in murine infection. Mol Cell Biol 1999; 19: 745-750.
24. Small JM, Mitchell TG. Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans scrotype A strains to capsule-free mutants. Infect Immun 1986; 54: 742-750.
25. Kozel TR, Gotschlich EC. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J Immunol 1982; 129: 1675-1680.
26. Steenbergen JN, Casadevall A. The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect 2003; 5: 667-675.
27. Mylonakis E, Ausubel FM, Perfect JR, Heitman J, Calderwood SB. Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc Natl Acad Sci USA 2002; 99: 15675-15680.
28. Chen SC, Currie BJ, Campbell HM, et al. Cryptococcus neoformans var. gattii infection in northern Australia: existence of an environmental source other than known host eucalypts. Trans R Soc Trap Med Hyg 1997; 91: 547-550.
29. Sorrell TC, Brownlee AG, Ruma P, et al. Natural environmental sources of Cryptococcus neoformans var. gattii. J Clin Microbiol 1996; 34: 1261-1263.
30. Finlay BJ, Esteban GF, Clarke KJ, Olmo JL. Biodiversity of terrestrial protozoa appears homogeneous across local and global spatial scales. Protist 2001; 152: 355-366.
31. Barbeau J, Buhler T. Biofilms augment the number of free-living amoebae in dental unit waterlines. Res Microbiol 2001; 152: 753-760.
32. Robinson BS, Bamforth SS, Dobson PJ. Density and diversity of protozoa in some and Australian soils. J Eukaryot Microbiol 2002; 49: 449-453.
33. Cherniak R, Sundstrom JB. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun 1994; 62: 1507-1512.